Exercise in Patients Admitted With Recently Decompensated Heart Failure
NCT ID: NCT04733365
Last Updated: 2021-02-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
250 participants
INTERVENTIONAL
2017-12-02
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Exercise in Patients Admitted With Recently Decompensated Heart Failure
NCT03838003
Impact of a Physical Exercise Program on the Self-care Capacity of People Hospitalized for Heart Failure
NCT06528561
Effectiveness of Combined Aerobic and Strength Training in Acute and Chronic Adaptations in Patients With Heart Failure
NCT03320655
Impact of Exercise Training on Exercise Capacity in Patients With Severe Chronic Heart Failure
NCT00176384
Exercise Therapy to Reduce Heart Failure Symptoms; Sorting Mechanisms of Benefit
NCT03648762
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Stage 1 - respiratory and calisthenic exercises (5-10 minutes) Stage 2 - pedaler for 5-10 minutes Stage 3 - aerobic training: walking on the corridor for 5-10 minutes Stage 4 - aerobic training: walking on the corridor for 10-15 minutes Stage 5 - aerobic training: walking on the corridor for 15 minutes + climbing stairs for 5 minutes
All patients will be monitored and followed up by a rehabilitation nurse while they are doing the exercise. The investigator decides, depending on the patient's performance and clinical conditions, the form of progression in the program, but it is mandatory to follow the previously defined levels of intensity. Patients in the test group may start the program only on stage I or II according to clinical criteria.
At admission of the patients (test group and control group) clinical and sociodemographic parameters are evaluated, as well as data related to Barthel's indices and London Chest of activities of daily living (LCADL). At the discharge date, the Barthel index and the LCADL scale will also be evaluated, as well as the 6-minute walking test.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Training group
Patients admitted due to decompensated heart failure who will perform the training protocol - ERIC protocol
ERIC protocol
ERIC protocol is an aerobic exercise protocol with 5 levels of intensity
Control group
Patients admitted due to decompensated heart failure who will perform the standard rehabilitation nursing care for this type of patients
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ERIC protocol
ERIC protocol is an aerobic exercise protocol with 5 levels of intensity
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* More than 18 years old
* Capacity to provide informed consent
Exclusion Criteria
* Existence of inotropic infusions;
* Dysrhythmia or precordial pain in the last 24 hours,
* Acute pulmonary edema in the last 12 hours,
* SBP greater than 180mmHg or less than 80 mmHg (except in cases where this is the baseline value for the patient),
* Need for oxygen at a rate greater than 3 l / min,
* Glycemic decompensation in the last 12 hours,
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centro Hospitalar do Porto
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bruno Miguel Delgado
Nurse
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bruno Delgado, MsC
Role: PRINCIPAL_INVESTIGATOR
Centro Hospitalar do Porto
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Infante D Pedro
Aveiro, , Portugal
Hospital Pulido Valente
Lisbon, , Portugal
Centro Hospitalar de Vila Nova de Gaia
Vila Nova de Gaia, , Portugal
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2016.172
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.